ARJO B Stock Overview
Develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Arjo AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr46.32 |
| 52 Week High | kr53.75 |
| 52 Week Low | kr34.18 |
| Beta | 0.31 |
| 1 Month Change | -0.86% |
| 3 Month Change | -5.12% |
| 1 Year Change | 7.67% |
| 3 Year Change | -46.42% |
| 5 Year Change | 15.45% |
| Change since IPO | 88.06% |
Recent News & Updates
Arjo (STO:ARJO B) Will Pay A Larger Dividend Than Last Year At SEK0.90
Apr 16
We Think Shareholders May Want To Consider A Review Of Arjo AB (publ)'s (STO:ARJO B) CEO Compensation Package
Apr 12Recent updates
Arjo (STO:ARJO B) Will Pay A Larger Dividend Than Last Year At SEK0.90
Apr 16We Think Shareholders May Want To Consider A Review Of Arjo AB (publ)'s (STO:ARJO B) CEO Compensation Package
Apr 12Arjo (STO:ARJO B) Is Increasing Its Dividend To SEK0.90
Mar 30Arjo (STO:ARJO B) Is Increasing Its Dividend To SEK0.90
Mar 16Arjo's (STO:ARJO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 02Arjo (STO:ARJO B) Is Increasing Its Dividend To SEK0.90
Feb 17Investors Appear Satisfied With Arjo AB (publ)'s (STO:ARJO B) Prospects As Shares Rocket 25%
Feb 06Arjo's (STO:ARJO B) Dividend Will Be Increased To SEK0.90
Feb 03Results: Arjo AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 01Arjo (STO:ARJO B) Seems To Use Debt Quite Sensibly
Oct 09Arjo (STO:ARJO B) Is Doing The Right Things To Multiply Its Share Price
Sep 18Are Investors Undervaluing Arjo AB (publ) (STO:ARJO B) By 44%?
May 30There's Been No Shortage Of Growth Recently For Arjo's (STO:ARJO B) Returns On Capital
May 17Here's Why Arjo (STO:ARJO B) Can Manage Its Debt Responsibly
Apr 21Arjo (STO:ARJO B) Will Pay A Smaller Dividend Than Last Year
Apr 05Arjo's (STO:ARJO B) Dividend Is Being Reduced To SEK0.85
Feb 25Arjo's (STO:ARJO B) Dividend Is Being Reduced To SEK0.85
Feb 11Arjo (STO:ARJO B) Will Pay A Smaller Dividend Than Last Year
Jan 28Is There An Opportunity With Arjo AB (publ)'s (STO:ARJO B) 48% Undervaluation?
Jan 17Be Wary Of Arjo (STO:ARJO B) And Its Returns On Capital
Dec 16Here's Why Arjo (STO:ARJO B) Can Manage Its Debt Responsibly
Oct 27Be Wary Of Arjo (STO:ARJO B) And Its Returns On Capital
Aug 24These 4 Measures Indicate That Arjo (STO:ARJO B) Is Using Debt Reasonably Well
May 25Arjo (STO:ARJO B) Has Some Way To Go To Become A Multi-Bagger
May 13Arjo (STO:ARJO B) Has Announced That It Will Be Increasing Its Dividend To kr1.15
Apr 12I Ran A Stock Scan For Earnings Growth And Arjo (STO:ARJO B) Passed With Ease
Apr 10Arjo (STO:ARJO B) Will Pay A Larger Dividend Than Last Year At kr1.15
Mar 29Arjo's (STO:ARJO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 06Arjo (STO:ARJO B) Will Pay A Larger Dividend Than Last Year At kr1.15
Feb 20Arjo (STO:ARJO B) Will Pay A Larger Dividend Than Last Year At kr1.15
Feb 06Shareholder Returns
| ARJO B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -0.4% | 0.9% | -1.3% |
| 1Y | 7.7% | -7.6% | 13.7% |
Return vs Industry: ARJO B exceeded the Swedish Medical Equipment industry which returned -7.6% over the past year.
Return vs Market: ARJO B underperformed the Swedish Market which returned 13.7% over the past year.
Price Volatility
| ARJO B volatility | |
|---|---|
| ARJO B Average Weekly Movement | 4.5% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.8% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: ARJO B has not had significant price volatility in the past 3 months.
Volatility Over Time: ARJO B's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 6,500 | Joacim Lindoff | www.arjo.com/int/ |
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions.
Arjo AB (publ) Fundamentals Summary
| ARJO B fundamental statistics | |
|---|---|
| Market cap | kr12.62b |
| Earnings (TTM) | kr499.00m |
| Revenue (TTM) | kr11.10b |
25.3x
P/E Ratio1.1x
P/S RatioIs ARJO B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARJO B income statement (TTM) | |
|---|---|
| Revenue | kr11.10b |
| Cost of Revenue | kr6.30b |
| Gross Profit | kr4.80b |
| Other Expenses | kr4.30b |
| Earnings | kr499.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 12, 2024
| Earnings per share (EPS) | 1.83 |
| Gross Margin | 43.22% |
| Net Profit Margin | 4.50% |
| Debt/Equity Ratio | 53.0% |
How did ARJO B perform over the long term?
See historical performance and comparison